Michael H. Xu-Chen - Publications

Incorporating frailty and disease severity into treatment decisions for older patients with ANCA-associated vasculitis.

Journal: Rheumatology (Oxford, England)

Published: August 15, 2025

Humoral responses to SARS-CoV-2 vaccine in vasculitis-related immune suppression.

Journal: Science advances

Published: February 12, 2025

Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trial.

Journal: BMC infectious diseases

Published: March 18, 2024

Impact of electronic AKI alert/care bundle on AKI inpatient outcomes: a retrospective single-center cohort study.

Journal: Renal failure

Published: February 12, 2024

Microfluidic antibody profiling after repeated SARS-CoV-2 vaccination links antibody affinity and concentration to impaired immunity and variant escape in patients on anti-CD20 therapy.

Journal: Frontiers in immunology

Published: September 18, 2023

The plethora of immunomodulatory drugs: opportunities for immune-mediated kidney diseases.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: April 24, 2023

PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V).

Journal: Trials

Published: December 11, 2022

Rare case of sudden onset sensorineural hearing loss in a patient diagnosed with sarcoidosis.

Journal: BMJ case reports

Published: July 12, 2022

Maxillary artery involvement in giant cell arteritis demonstrated by ultrasonography.

Journal: The journal of the Royal College of Physicians of Edinburgh

Published: December 09, 2021

Periorbital purpura of AL amyloidosis.

Journal: Rheumatology (Oxford, England)

Published: September 18, 2020